A key objective in Sweden's national life science strategy is to increase the number of high-quality clinical trials. Clinical trials are not only important for generating new knowledge about the safety and efficacy of pharmaceuticals – they also enable the healthcare system to implement new treatments more quickly and provide patients with early access to innovative therapies.
Hagastaden is a hub for innovation in life science. The area is growing, and we’ll take a closer look at how the companies based here are doing. During our Afternoon Tea on May 15, you’ll get the latest figures on the local business climate, followed by a panel discussion on investments, new establishments, and confidence in the future during uncertain times.
TEFs (European Testing and Experimentation Facilities) are large-scale testing environments where European technology providers can trial their AI-based software and hardware technologies in both physical and virtual settings. TEF-Health aims to both accelerate the introduction of AI and robotics in healthcare and promote collaboration.
SciLifeLab, Sweden's national center for molecular biosciences, supports the life science industry by providing access to its advanced research infrastructure. Each year, over 100 different companies, ranging from large corporations to small and medium-sized enterprises engage with SciLifeLab's infrastructure, fostering knowledge transfer between academia and industry.